Conditions & Recovery · Cancer Health Science · October 8, 2026

Experimental Vaccine Shows Promise for Glioblastoma Brain Cancer

SurVaxM prolonged survival for newly diagnosed patients, especially those ages 65 and under.

Originally published by Cancer Health Science. We curate and add context; they did the reporting.

Related learning